Kiromic Biopharma, Inc.
SEC CIK 1792581 · KRBP · last insider filing 2024-08-26
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Bersani Pietro | Director · Chief Executive Officer | filed 2020 - 2024 |
| Misajon Pamela | Director | filed 2023 - 2024 |
| Nagel Michael | Director | filed 2020 - 2024 |
| Catlin Michael | Director | filed 2023 - 2024 |
| Cicchetti Americo | Director | filed 2020 - 2022 |
| Tirelli Francis X | Director | filed 2022 - 2022 |
| Reeves Karen | Director | filed 2022 - 2022 |
| Chiriva Internati Maurizio | Director · Chairman, CEO, and President | filed 2020 - 2021 |
| Rotino Gianluca | Director · See Remarks | filed 2020 - 2021 |
| Schneider Jerry A. | Director | filed 2020 - 2021 |
| Tontat Tony | Director · CFO AND COO | filed 2020 - 2021 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Hungerford Brian | Chief Financial Officer | filed 2023 - 2024 |
| Mirandola Leonardo | CSO | filed 2024 - 2024 |
| Dahlbeck Scott | Chief of Staff | filed 2020 - 2022 |
| Clark Daniel Grant | Interim CFO | filed 2021 - 2022 |
| Ryan Michael Charles | See Remarks | filed 2021 - 2021 |
| Nunez Ignacio | See Remarks | filed 2021 - 2021 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.